The direct-to-consumer (DTC) genetic testing market is projected to grow at a CAGR of ~12% over the forecast period. Major ...

The genomic biomarkers market is experiencing rapid growth, driven by advancements in precision medicine, early disease ...

Shares of Myriad Genetics were higher after it announced early access to the FirstGene Multiple Prenatal Screen. The stock was up 9.2% to $4.87 Tuesday and is down about 64% this year.

Screening test provides prenatal risk assessment for common genetic conditions in one blood draw without the need for ...

Of the 30 companies included in the list, 15 saw their stock prices decline, while 15 saw their share prices rise.

MONSTAR-SCREEN-3 study showed 100% detection of circulating tumor DNA (ctDNA) at baseline timepoint, and 60% of patients ...

Forests cover almost one-third of the Earth’s land area, providing crucial benefits for both people and the environment. They protect soil and water, regulate the climate and safeguard biodiversity.

Vepdegestrant, an investigational estrogen receptor (ER) degrader, known as a proteolysis-targeting chimera (PROTAC ), ...

Many patients with ER-positive/HER2-negative advanced breast cancer eventually develop resistance to standard first-line ...

Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful ...